Edson Pontes

849 total citations
27 papers, 673 citations indexed

About

Edson Pontes is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Edson Pontes has authored 27 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 9 papers in Oncology and 8 papers in Surgery. Recurrent topics in Edson Pontes's work include Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Edson Pontes is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Bladder and Urothelial Cancer Treatments (6 papers). Edson Pontes collaborates with scholars based in United States, Spain and France. Edson Pontes's co-authors include David P. Wood, Jeffrey D. Forman, Arthur T. Porter, James H. Finke, David J. Grignon, Ronald M. Bukowski, Jeannine Alexander, Falah Shamsa, Mark Edinger and Patricia Rayman and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of the New York Academy of Sciences.

In The Last Decade

Edson Pontes

26 papers receiving 641 citations

Peers

Edson Pontes
Lawrence Einhorn United States
Zhaoli Lane United States
Katherine S. Tzou United States
C. H. W. Horne United Kingdom
Subir Goyal United States
F Salvati Italy
C. Norman Coleman United States
Debasish Sundi United States
Lawrence Einhorn United States
Edson Pontes
Citations per year, relative to Edson Pontes Edson Pontes (= 1×) peers Lawrence Einhorn

Countries citing papers authored by Edson Pontes

Since Specialization
Citations

This map shows the geographic impact of Edson Pontes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edson Pontes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edson Pontes more than expected).

Fields of papers citing papers by Edson Pontes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edson Pontes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edson Pontes. The network helps show where Edson Pontes may publish in the future.

Co-authorship network of co-authors of Edson Pontes

This figure shows the co-authorship network connecting the top 25 collaborators of Edson Pontes. A scholar is included among the top collaborators of Edson Pontes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edson Pontes. Edson Pontes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aoun, Hussein D., et al.. (2021). Percutaneous cryoablation of adrenal metastases: technical feasibility and safety. Abdominal Radiology. 46(6). 2805–2813. 5 indexed citations
2.
Aoun, Hussein D., Peter J. Littrup, Mohamed Jaber, et al.. (2017). Percutaneous Cryoablation of Renal Tumors: Is It Time for a New Paradigm Shift?. Journal of Vascular and Interventional Radiology. 28(10). 1363–1370. 47 indexed citations
3.
Sakr, Wael, Shanthi Marur, M. Che, et al.. (2007). Expression of EGFR, HER-2 and p53 predictive of prognosis in muscle-invasive bladder cancer. Journal of Clinical Oncology. 25(18_suppl). 15637–15637. 1 indexed citations
4.
Patel, Bhaumik B., Jeffrey D. Forman, Joseph A. Fontana, et al.. (2005). A single institution experience with concurrent capecitabine and radiation therapy in weak and/or elderly patients with urothelial cancer. International Journal of Radiation Oncology*Biology*Physics. 62(5). 1332–1338. 23 indexed citations
5.
Vaishampayan, Ulka N., Lance K. Heilbrun, James F. Eliason, et al.. (2005). Docetaxel and capecitabine in metastatic androgen independent prostate cancer (AIPC): Phase II trial to detect clinical efficacy of a synergistic combination. Journal of Clinical Oncology. 23(16_suppl). 4703–4703. 2 indexed citations
6.
Garg, Madhur, Samuel Tekyi‐Mensah, Edson Pontes, et al.. (1998). Impact of Postprostatectomy Prostate-Specific Antigen Nadir on Outcomes Following Salvage Radiotherapy. Urology. 51(6). 998–1002. 79 indexed citations
7.
Wood, David P., et al.. (1998). Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.. PubMed. 4(9). 2119–23. 14 indexed citations
8.
Porter, A.T., et al.. (1998). The organization and economics of prostate seed implantation programs.. PubMed. 7(3). 16–20. 2 indexed citations
9.
Ravery, V., David J. Grignon, J.C. Angulo, et al.. (1997). Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer. Urological Research. 25(1). 9–17. 62 indexed citations
10.
Forman, Jeffrey D., et al.. (1997). THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POST-PROSTATECTOMY PROSTATE SPECIFIC ANTIGEN LEVEL. The Journal of Urology. 1439–1440. 4 indexed citations
11.
Forman, Jeffrey D., et al.. (1997). THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POST-PROSTATECTOMY PROSTATE SPECIFIC ANTIGEN LEVEL. The Journal of Urology. 158(4). 1436–1440. 81 indexed citations
12.
Forman, Jeffrey D., et al.. (1997). THERAPEUTIC IRRADIATION FOR PATIENTS WITH AN ELEVATED POST-PROSTATECTOMY PROSTATE SPECIFIC ANTIGEN LEVEL. The Journal of Urology. 1436–1439. 3 indexed citations
13.
Filho, Vicente Odone, et al.. (1994). Teniposide plus cytarabine as intensification therapy and in continuation therapy for advanced nonlymphoblastic lymphomas of childhood.. Journal of Clinical Oncology. 12(9). 1963–1968. 5 indexed citations
14.
Alexander, Jeannine, Patricia Rayman, Mark Edinger, et al.. (1990). Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activity. International Journal of Cancer. 45(1). 119–124. 31 indexed citations
15.
Finke, James H., Patricia Rayman, Jeannine Alexander, et al.. (1990). Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma.. PubMed. 50(8). 2363–70. 74 indexed citations
16.
Finke, James H., R Tubbs, Barbara A. Connelly, Edson Pontes, & James E. Montie. (1988). Tumor‐Infiltrating Lymphocytes in Patients with Renal‐Cell Carcinoma. Annals of the New York Academy of Sciences. 532(1). 387–394. 41 indexed citations
17.
Murphy, Gerald P., et al.. (1984). Effect of Combination Chemotherapy on Murine Bladder Cancer. Oncology. 41(6). 414–416. 5 indexed citations
18.
Pj, Creaven, Stefan Madajewicz, Lakshmi Pendyala, et al.. (1983). Phase I clinical trial of cis-dichloro-trans-dihydroxy-bis-isopropylamine platinum(IV) (CHIP).. PubMed. 67(9). 795–800. 52 indexed citations
19.
Pontes, Edson, Martin H. Goldrosen, & G.P. Murphy. (1983). Immunological Response to Tumor Ischemia in a Murine Renal Cell Carcinoma Model. Oncology. 40(1). 63–66. 3 indexed citations
20.
Huben, Robert, Nachimuthu Natarajan, Edson Pontes, et al.. (1982). Carcinoma of prostate in men less than fifty years old Data from American College of Surgeons' national survey. Urology. 20(6). 585–588. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026